MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
35 hedge funds and large institutions have $137M invested in MyoKardia, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.9M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.21M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.55M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.13M |
Top Sellers
MYOK Hedge Fund Activity: Q4 2015 in Review
35 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q4 2015, worth a combined $137M.
Buyers outnumbered sellers: 35 funds opened new MYOK positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $48.1M.
- 35 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $137M of MyoKardia, Inc. Common Stock stock for Q4 2015.
- 35 funds opened new MyoKardia, Inc. Common Stock positions in Q4 2015 and 0 closed out, a net change of +35 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q4 2015 was Fidelity Investments, an estimated $48.1M added.
Based on aggregated 13F filings for Q4 2015.